Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient
Experimental and Clinical Transplantation · 2023
DOI: 10.6002/ect.2023.0018 ↗At a glance
Fallbericht in Experimental and Clinical Transplantation, 2023. Written by Theodoros Eleftheriadis and 4 co-authors. Institution: From the Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa, Greece. Major MEDLINE topics: Carcinoma, Squamous Cell, Kidney Transplantation, Skin Neoplasms. Cited 1 times so far (Crossref); 8 references.
Abstract (original language)
A 56-year-old male living donor kidney transplant recipient presented with a giant cutaneous squamous cell carcinoma in his right parotid region. Programmed radiotherapy had been previously terminated due to lesion ulceration and bleeding. He was characterized as a terminal case. We applied cemiplimab, which is an immune checkpoint inhibitor against the pro-grammed cell death receptor PD-1. After 6 months, the cutaneous squamous cell carcinoma had shrunk and had stopped bleeding. The patient was treated with methylprednisolone, cyclosporine, and mycophenolate mofetil during this period. He had 2 rejection episodes defined as doubling baseline serum creatinine with no other explanation. Both episodes were successfully treated with intravenous methylprednisolone, while immunotherapy was postponed for 10 days. In both cases, serum creatinine returned to baseline within 1 week. Immune checkpoint inhibitors are indicated for invasive cutaneous squamous cell carcinoma therapy, and the risk of acute rejection should not prevent the use of these agents in kidney transplant recipients, because immune checkpoint inhibitors may enhance the quantity and quality of life of such patients.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- From the Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Cite
APA
Eleftheriadis, T., Samaras, I., Spanos, A., Kotsakis, A., & Stefanidis, I. (2023). Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient. Experimental and Clinical Transplantation. https://doi.org/10.6002/ect.2023.0018
Vancouver
Eleftheriadis T, Samaras I, Spanos A, Kotsakis A, Stefanidis I. Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient. Experimental and Clinical Transplantation. 2023. doi:10.6002/ect.2023.0018
BibTeX
@article{Eleftheriadis2023,
author = {Eleftheriadis, Theodoros and Samaras, Ioannis and Spanos, Antonios and Kotsakis, Athanasios and Stefanidis, Ioannis},
title = {Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient},
journal = {Experimental and Clinical Transplantation},
year = {2023},
doi = {10.6002/ect.2023.0018}
}
EUVIMED